Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human CXCL8 mutant

EU orphan designation number: EU/3/08/570   
Active ingredient: Recombinant human CXCL8 mutant
Indication: Prevention of delayed graft function after solid organ transplantation
Sponsor: ProtAffin Biotechnologie AG
Impulszentrum Graz-West, Reininghausstrasse 13a, A-8020 Graz, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2008 Orphan designation EMEA/OD/026/08 (2008)5452 of 22/09/2008